Rhino-Orbital and Breast Mucormycosis After COVID-19: A Case Report

Authors

  • Mahshid Talebi-Taher Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Nahid Nafisi Department of Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Anis Ourang Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.18502/jimc.v5i2.10473

Keywords:

COVID-19, Humans, Invasive fungal infections, Mucormycosis

Abstract

The recent rise of Invasive Fungal Infections (IFI), especially mucormycosis in COVID-19 patients, is further complicating the outcomes. Here, we present a case of concomitant rhino-orbital and breast mucormycosis after COVID-19. To the best of our knowledge, this is the first case of breast mucormycosis after COVID-19.

Downloads

Published

2022-08-31

Issue

Section

Articles